REFERENCES
- Amato Neto, V., Moreira, A. A., Chiaramelli, M. C., Lemej. M., Chiramelli, D. R., Campos, R., Pinto, P. L., Santana, E. J. & Rocha, S. (1985). Demarcacao da actividade anti-helmintica do albendazol. Estudo referente a estrongyloidiase humana. Revista do Instituto de Medicina Tropical de Sao Paulo, 27, 95–98.
- Aur, R. J. A., Pratt, C. B. & Johnson, W. W. (1971). Thiabendazole in visceral larva migrans. American Journal of Diseases of Children, 121, 226–229.
- Awad Abdel-Hameed, A. (1984). Effect of thiabendazole on the migration of Toxocara canis larvae in the mouse. Journal of Parasitology, 70, 226–231.
- Barrowman, M. M., Marriner, S. E. & Boga, J. A. (1984). The binding and subsequent inhibition of tubulin polymerization in Ascaris suum (in vitro) by benzimidazole antihelminthics. Biochemical Pharmacology, 33, 3037–3040.
- Beaver, P. C., Snyder, C. H., Carrera, G. M., Dent, J. H. & Lafferty, J. W. (1952). Chronic eosinophilia due to visceral larva migrans. Pediatrics, 9, 7–19.
- Botey, M. A. (1988). Desarrollo clínico mundial del albendazol. Investigacion Medica Internacional, 15, 4–8.
- Campbell, W. C. (1971). Thiabendazole effects in visceral larva migrans. Journal of the American Medical Association, 217, 342–343.
- Dent, J. H., Nichols, R. L., Beaver, P. C., Cabrera, G. M. & Staggers, R. J. (1956). Viscerallarva migrans: with a case report. American Journal of Pathology, 32, 777–803.
- Escobedo, F., Penagos, P., Rodriguez, J. & Sotelo, J. (1987). Albendazole therapy for neurocysticercosis. Archives of Internal Medicine, 147, 738–741.
- Marriner, S. E., Morris, D. L., Dickson, B. & Bogan, J. A. (1986). Pharmacokinetics of albendazole in man. European Journal of Clinical Pharmacology, 30, 705–708.
- Martindale, E. (1982). The Extra Pharmacopoeia, ed. Reynolds, J. London: The Pharmaceutical Press.
- Morris, D. L., Dykes, P. W., Dickson, B., Marriner, S. E. & Bogan, J. A. (1983). Albendazole in hydatid disease. British Medical Journal, 286, 103–104.
- Morris, D. L., Dykes, P. W., Marriner, S., Bogan, J., Burrows, F., Skeene-Smith, H. & Clarkson, M. J. (1985). Albendazole—objective evidence of response in human hydatid disease. Journal of the American Medical Association, 253, 2053–2057.
- Nelson, J. D., McConnell, H. & Moore, D. V. (1966). Thiabendazole therapy of visceral larva migrans: a case report. American Journal of Tropical Medicine and Hygiene, 15, 930–933.
- Nichols, R. L. (1956). The etiology of visceral larva migrans. Journal of Parasitology, 42, 349–357.
- Penicaut, B., Beck, C., Maugein, Ph., Parish, R., Randolph, W., Di Cuolle, C. J. & Rossignol, J. F. (1981). Albendazol: perfil farmacocinético. Comp. de lnv. Clin. Latin., 1, 61–77.
- Pugh, R. N. H. (1986). Albendazole in children with hookworm infection. Annals of Tropical Medicine and Parasitology, 80, 565–567.
- Rahemtulla, A., Bryceson, A. D. & McManus, D. P. (1987). Albendazole in the treatment of hydatid disease. Journal of the Royal Society of Medicine, 80, 119–120.
- Schantz, P. & Glickman, L. T. (1983). Ascaridos de perros y gatos: un problema de salud publica y de medicina veterinaria. Boletin de la Oficina Sanitaria Panamericana, 94, 571–585.
- Szypryt, E. P., Morris, D. L. & Mulholland, R. C. (1987). Combined chemotherapy and surgery for hydatid bone disease. Journal of Bone and Joint Surgery, 69, 141–144.
- Woodruff, A. W. (1970). Toxocariasis. British Medical Journal, 3, 663–669.